Wakelee HA - Search Results

1

Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapy.

Lynch TJ Jr, Blumenschein GR Jr, Engelman JA, Espinoza-Delgado I, Govindan R, Hanke J, Hanna NH, Heymach JV, Hirsch FR, Janne PA, Lilenbaum RC, Natale RB, Riely GJ, Sequist LV, Shapiro GI, Shaw A, Shepherd FA, Socinski M, Sorensen AG, Wakelee HA, Weitzman A. Lynch TJ Jr, et al. Among authors: wakelee ha. J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S107-12. doi: 10.1097/JTO.0b013e318174e9d3. J Thorac Oncol. 2008. PMID: 18520291 Free article.

2

Activity of novel cytotoxic agents in lung cancer: epothilones and topoisomerase I inhibitors.

Wakelee HA, Sikic BI. Wakelee HA, et al. Clin Lung Cancer. 2005 Sep;7 Suppl 1:S6-12. doi: 10.3816/clc.2005.s.002. Clin Lung Cancer. 2005. PMID: 16159420 Review.

3

Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial.

Wakelee HA, Schiller JH, Gandara DR. Wakelee HA, et al. Clin Lung Cancer. 2006 Jul;8(1):18-21. doi: 10.3816/CLC.2006.n.028. Clin Lung Cancer. 2006. PMID: 16870041 Review.

4

Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594.

Wakelee HA, Wang W, Schiller JH, Langer CJ, Sandler AB, Belani CP, Johnson DH; Eastern Cooperative Oncology Group. Wakelee HA, et al. J Thorac Oncol. 2006 Jun;1(5):441-6. J Thorac Oncol. 2006. PMID: 17409897 Free article. Clinical Trial.

5

Adjuvant chemotherapy of stage I non-small cell lung cancer in North America.

Gandara DR, Wakelee H, Calhoun R, Jablons D. Gandara DR, et al. J Thorac Oncol. 2007 Jul;2(7 Suppl 3):S125-7. doi: 10.1097/JTO.0b013e318074fe31. J Thorac Oncol. 2007. PMID: 17603308 Free article.

6

Cooperative group research efforts in lung cancer: focus on early-stage non-small-cell lung cancer.

Wakelee H, Langer C, Vokes E, Schiller J, Baas P, Saijo N, Adjei A, Shepherd F, Choy H, Gandara DR. Wakelee H, et al. Clin Lung Cancer. 2008 Jan;9(1):9-15. doi: 10.3816/CLC.2008.n.002. Clin Lung Cancer. 2008. PMID: 18282352 Review.

7

Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?

Langer CJ, Wakelee H, Schiller J, Choy H, Shepherd F, Vokes EE, Adjei AA, Baas P, Saijo N, Gandara DR. Langer CJ, et al. Clin Lung Cancer. 2008 Mar;9(2):85-91. doi: 10.3816/CLC.2008.n.013. Clin Lung Cancer. 2008. PMID: 18501094 Review.

8

Antibodies to vascular endothelial growth factor in non-small cell lung cancer.

Wakelee H. Wakelee H. J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S113-8. doi: 10.1097/JTO.0b013e318174e993. J Thorac Oncol. 2008. PMID: 18520292 Free article. Review.

9

Vascular endothelial growth factor pathway.

Krupitskaya Y, Wakelee H. Krupitskaya Y, et al. J Thorac Oncol. 2009 Nov;4(11 Suppl 3):S1071-3. doi: 10.1097/01.JTO.0000361755.32660.a1. J Thorac Oncol. 2009. PMID: 19861922 Free article. No abstract available.

10

Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress.

Wakelee H, Loo BW Jr, Kernstine KH, Putnam JB Jr, Edelman MJ, Vokes EE, Schiller JH, Baas P, Saijo N, Adjei A, Goss G, Choy H, Gandara DR. Wakelee H, et al. Clin Lung Cancer. 2009 Nov;10(6):395-404. doi: 10.3816/CLC.2009.n.075. Clin Lung Cancer. 2009. PMID: 19900856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters